TCW Group Inc. filed a Form 4 with the SEC on November 17, 2026, disclosing the cancellation of ten warrant tranches and the acquisition of Series A Convertible Preferred Stock in Accuray Inc. (NASDAQ:ARAY) on November 13, 2026.
Key Highlights
- Warrant cancellations: Ten warrants to purchase Accuray common stock, with exercise prices of $67.2, $60, and $50 per share and expiration dates ranging from June 6, 2032 to May 19, 2033, were cancelled for no separate consideration on November 13, 2026.
- Preferred Stock acquired: TCW's affiliated Holders were issued a combined 30,959 shares of Series A Convertible Preferred Stock on November 13, 2026, at a purchase price of $1,000 per share.
- Consideration mix: The Preferred Stock was funded through a cash investment of $10,625,000 and the cancellation of $20,333,333.31 of indebtedness held by the Holders under the Financing Agreement.
- Conversion terms: Each share of Preferred Stock has a stated value of $1,000 and is convertible into Accuray common stock at an initial conversion price of $20.00 per share, subject to adjustment per the Certificate of Designations.
- Remaining warrants: Following the cancellations, TCW's business unit holds warrants to purchase 337,998 shares of Accuray common stock at an exercise price of $0.01 per share, subject to a 19.9% beneficial ownership cap.
- Reverse stock split: Accuray effected a 1-for-40 reverse stock split on November 9, 2026; all share counts and prices in the filing reflect post-split figures.
- Reporting relationship: TCW is identified in the filing as a 10% owner of Accuray Inc.
TCW Business Unit's Warrant Cancellations and Preferred Stock Issuance Under the SPA
According to the filing, the ten cancelled warrants were held of record by TCW Rescue Financing Fund II LP, West Virginia Direct Lending LLC, and TCW WV Financing LLC, collectively referred to as the Holders, each forming part of the TCW Business Unit. The cancellations were made for no separate consideration and occurred in connection with the closing under a Securities Purchase Agreement (SPA) dated July 29, 2026, as amended on November 13, 2026, and a Limited Waiver and Amendment No. 3 to the Financing Agreement dated June 6, 2025.
The filing states that on November 13, 2026, TCW Rescue Financing Fund II LP and TCW WV Financing LLC received a combined 30,959 shares of Series A Convertible Preferred Stock from Accuray. The aggregate consideration consisted of a $10,625,000 cash investment, originally funded on July 29, 2026, and the cancellation of $20,333,333.31 of outstanding indebtedness under the Financing Agreement. Accuray is a medical device company whose securities are listed on NASDAQ:ARAY. The Preferred Stock carries no expiration date and is convertible at any time at the option of the holder, with the initial conversion price set at $20.00 per share.
The filing further discloses that after these transactions, the TCW Business Unit retains warrants to purchase 337,998 shares of Accuray common stock at $0.01 per share. Those remaining warrants include a provision prohibiting exercise if the holder and its affiliates would, as a result, beneficially own more than 19.9% of Accuray's outstanding common stock, according to the filing. TCW disclaims beneficial ownership of securities held by the Holders beyond any pecuniary interest it may have, directly or indirectly.
What Was Disclosed
TCW Group Inc. reported the November 13, 2026 cancellation of ten Accuray warrant positions for no consideration and the concurrent acquisition of 30,959 shares of Series A Convertible Preferred Stock, funded partly by cash and partly by debt cancellation, under a Securities Purchase Agreement with Accuray Inc.





Please wait processing your request...